First in human study for Huntington’s disease led by UCL academic

The first patient has begun treatment on a global trial of a novel medication for Huntington’s disease, led within the UK by Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology).

Read: Independent, More: STV News, The Standard, Express, Mail Online, Belfast Telegraph, The Herald, The National, The Northern Echo, Irish News (Ireland), UCL News